N-terminal fragment of pro-B-type natriuretic peptide is a predictor of cardiac events in high-risk patients undergoing acute hip fracture surgery

British Journal of Anaesthesia

Volumn 103, Issue 2, 2009, Pages 206-212

  Oscarsson, A ^a   Fredrikson, M ^b   Sorliden M ^a   Anskar S ^a   Eintrei, C ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Complications, morbidity; Heart, myocardial function; Surgery, non cardiac; Surgery, orthopaedic

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; EMERGENCY SURGERY; FEMALE; HEART DISEASE; HEART FUNCTION; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 68149099056     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep139     Document Type: Article

References (30)

1. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997; 7: 407-413
2. Roberts SE, Goldacre MJ. Time trends and demography of mortality after fractured neck of femur in an English population, 1968-1998: database study. Br Med J 2003; 327: 771-775
3. Todd CJ, Palmer C, Camilleri-Ferrante C, et al. Differences in mortality after fracture of hip. Br Med J 1995; 310: 904-908
4. Dawson-Bowling S, Chettiar K, Cottam H, et al. Troponin T as a predictive marker of morbidity in patients with fractured neck of femur. Injury 2008; 39: 775-780
5. Weatherall M. One year follow up of patients with fracture of the proximal femur. N Z Med J 1994; 107: 308-309
6. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442
7. Johansen H, Strauss B, Arnold JM, Moe G, Liu P. On the rise: the current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol 2003; 19: 430-435 (Pubitemid 36603512)
8. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81 (Pubitemid 18083551)
9. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167 (Pubitemid 34764819)
10. Sear JW, Howard-Alpe G. Preoperative plasma BNP concentrations: do they improve our care of high-risk non-cardiac surgical patients? Br J Anaesth 2007; 99: 151-154
11. Richards AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003; 107: 2786-2792 (Pubitemid 36705987)
12. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002; 105: 2392-2397 (Pubitemid 34556391)
13. Gibson SC, Payne CJ, Byrne DS, Berry C, Dargie HJ, Kingsmore DB. B-type natriuretic peptide predicts cardiac morbidity and mortality after major surgery. Br J Surg 2007; 94: 903-909 (Pubitemid 47051217)
14. Rajagopalan S, Croal BL, Bachoo P, Hillis GS, Cuthbertson BH, Brittenden J. N-terminal pro B-type natriuretic peptide is an independent predictor of postoperative myocardial injury in patients undergoing major vascular surgery. J Vasc Surg 2008; 48: 912-917
15. Cuthbertson BH, Amiri AR, Croal BL, et al. Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth 2007; 99: 170-176 (Pubitemid 47249387)
16. Eliasdottir SB, Klemenzson G, Torfason B, Valsson F. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiol Scand 2008; 52: 182-187
17. Dernellis J, Panaretou M. Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients. Heart 2006; 92: 1645-1650 (Pubitemid 44629177)
18. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-1049
19. Mark DB, Felker GM. B-type natriuretic peptide - a biomarker for all seasons? N Engl J Med 2004; 350: 718-720
20. Baughman KL. B-type natriuretic peptide - a window to the heart. N Engl J Med 2002; 347: 158-159 (Pubitemid 34764818)
21. Cuthbertson BH, Card G, Croal BL, McNeilly J, Hillis GS. The utility of B-type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major emergency non-cardiac surgery. Anaesthesia 2007; 62: 875-881 (Pubitemid 47261789)
22. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350: 647-654 (Pubitemid 38364623)
23. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-1021 (Pubitemid 34940793)
24. Feringa HH, Bax JJ, Elhendy A, et al. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Am J Cardiol 2006; 98: 111-115 (Pubitemid 43902686)
25. Rodseth RN, Padayachee L, Biccard BM. A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 2008; 63: 1226-1233
26. Perez JV, Warwick DJ, Case CP, Bannister GC. Death after proximal femoral fracture - an autopsy study. Injury 1995; 26: 237-240
27. Roche JJ, Wenn RT, Sahota O, Moran CG. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. Br Med J 2005; 331: 1374-1379 (Pubitemid 43773489)
28. Kertai MD, Boersma E, Bax JJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003; 89: 1327-1334 (Pubitemid 37311098)
29. Mahla E, Baumann A, Rehak P, et al. N-terminal pro-brain natriuretic peptide identifies patients at high risk for adverse cardiac outcome after vascular surgery. Anesthesiology 2007; 106: 1088-1095 (Pubitemid 46828160)
30. Goei D, Schouten O, Boersma E, et al. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. Am J Cardiol 2008; 101: 122-126 (Pubitemid 350297209)